TLSI
TriSalus Life Sciences, Inc.
NASDAQ · USHealthcareMedical - Devices
$4.31+0.47%
Price as of Jul 20, 2026
TLSI valuation
TriSalus Life Sciences, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 44.58x
- P/E 2028E
- 12.10x
- P/S forward
- 3.18x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 20.67x
- Price / sales
- 5.90x
- Price / cash flow
- -13.24x
Enterprise value
- Enterprise value
- $242.6M
- EV / sales
- 5.41x
- EV / EBITDA
- -11.58x
- EV / EBIT
- -8.66x
- Market cap
- $264.7M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.